Paul J. Sabbatini

Oncology
160 E 53rd St
New York, NY 10022

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications

Evaluating the Impact of Electronic Health Record to Electronic Data Capture Technology on Workflow Efficiency: a Site Perspective.

Evaluating the Impact of Electronic Health Record to Electronic Data Capture Technology on Workflow Efficiency: a Site Perspective.

Journal: JAMIA open
Published: February 06, 2025

Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody-drug conjugate.

Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody-drug conjugate.

Journal: Gynecologic oncology
Published: January 27, 2025

Optimizing Mainstreaming of Genetic Testing in Parallel With Ovarian and Endometrial Cancer Tumor Testing: How Do We Maximize Our Impact?

Optimizing Mainstreaming of Genetic Testing in Parallel With Ovarian and Endometrial Cancer Tumor Testing: How Do We Maximize Our Impact?

Journal: JCO precision oncology
Published: December 23, 2024

Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival.

Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival.

Journal: Gynecologic oncology
Published: October 06, 2023

Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer.

Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer.

Journal: Cancer discovery
Published: May 11, 2023

Carboplatin dosing in the treatment of ovarian cancer: An NRG oncology group study.

Carboplatin dosing in the treatment of ovarian cancer: An NRG oncology group study.

Journal: Gynecologic oncology
Published: February 24, 2023

Phase I Study of a Multivalent WT1 Peptide Vaccine (Galinpepimut-S) in Combination with Nivolumab in Patients with WT1-Expressing Ovarian Cancer in Second or Third Remission.

Phase I Study of a Multivalent WT1 Peptide Vaccine (Galinpepimut-S) in Combination with Nivolumab in Patients with WT1-Expressing Ovarian Cancer in Second or Third Remission.

Journal: Cancers
Published: January 19, 2023

Digitalizing the Clinical Research Informed Consent Process: Assessing the Participant Experience in Comparison With Traditional Paper-Based Methods.

Digitalizing the Clinical Research Informed Consent Process: Assessing the Participant Experience in Comparison With Traditional Paper-Based Methods.

Journal: JCO oncology practice
Published: December 19, 2022

Clinical Trial Participation Among Older Adult Medicare Fee-for-Service Beneficiaries With Cancer.

Clinical Trial Participation Among Older Adult Medicare Fee-for-Service Beneficiaries With Cancer.

Journal: JAMA oncology
Published: October 27, 2022

Association of patient activity bio-profiles with health-related quality of life in patients with newly diagnosed multiple myeloma: a prospective observational cohort study.

Association of patient activity bio-profiles with health-related quality of life in patients with newly diagnosed multiple myeloma: a prospective observational cohort study.

Journal: EClinicalMedicine
Published: September 20, 2022

Small cell neuroendocrine carcinoma of the cervix: Analysis of prognostic factors and patterns of metastasis.

Small cell neuroendocrine carcinoma of the cervix: Analysis of prognostic factors and patterns of metastasis.

Journal: Gynecologic oncology reports
Published: June 27, 2022

Validation of a Population-Based Data Source to Examine National Cancer Clinical Trial Participation.

Validation of a Population-Based Data Source to Examine National Cancer Clinical Trial Participation.

Journal: JAMA network open
Published: March 22, 2022
Showing 1-12 of 58

Last Updated: 09/26/2026